These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 16969258

  • 1. Evaluation of transcriptional activity of the oestrogen receptor with sodium iodide symporter as an imaging reporter gene.
    Kang JH, Chung JK, Lee YJ, Kim KI, Jeong JM, Lee DS, Lee MC.
    Nucl Med Commun; 2006 Oct; 27(10):773-7. PubMed ID: 16969258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells.
    Matsumura A, Ghosh A, Pope GS, Darbre PD.
    J Steroid Biochem Mol Biol; 2005 Apr; 94(5):431-43. PubMed ID: 15876408
    [Abstract] [Full Text] [Related]

  • 7. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H, Bergert ER, Spitzweg C, Cheville JC, Lieber MM, Morris JC.
    Cancer Res; 2003 Nov 15; 63(22):7840-4. PubMed ID: 14633711
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS).
    Fortunati N, Catalano MG, Marano F, Mugoni V, Pugliese M, Bosco O, Mainini F, Boccuzzi G.
    Breast Cancer Res Treat; 2010 Dec 15; 124(3):667-75. PubMed ID: 20213084
    [Abstract] [Full Text] [Related]

  • 11. Enhanced formation of non-phenolic androgen metabolites with intrinsic oestrogen-like gene transactivation potency in human breast cancer cells: a distinctive metabolic pattern.
    Pérez-Palacios G, Santillán R, García-Becerra R, Borja-Cacho E, Larrea F, Damián-Matsumura P, González L, Lemus AE.
    J Endocrinol; 2006 Sep 15; 190(3):805-18. PubMed ID: 17003281
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oestrogenic activity of benzyl salicylate, benzyl benzoate and butylphenylmethylpropional (Lilial) in MCF7 human breast cancer cells in vitro.
    Charles AK, Darbre PD.
    J Appl Toxicol; 2009 Jul 15; 29(5):422-34. PubMed ID: 19338011
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction of stimulated sodium iodide symporter expression by estrogen receptor ligands in breast cancer cells.
    Cheong SJ, Jang D, Jeong HJ, Lim ST, Sohn MH, Katzenellenbogen JA, Kim DW.
    Nucl Med Biol; 2011 Feb 15; 38(2):287-94. PubMed ID: 21315285
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
    Maru BS, Tobias JH, Rivers C, Caunt CJ, Norman MR, McArdle CA.
    Bone; 2009 Jan 15; 44(1):102-12. PubMed ID: 18976723
    [Abstract] [Full Text] [Related]

  • 20. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ, Sharif Samani BR, Klutz K, Cengic N, Wolf I, Mohr L, Geissler M, Senekowitsch-Schmidtke R, Göke B, Morris JC, Spitzweg C.
    Gene Ther; 2008 Feb 15; 15(3):214-23. PubMed ID: 17989705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.